VarickRX is the only pharmacy operations platform purpose-built for Critical Access Hospitals — so you capture full 340B savings without building the infrastructure yourself.
Complete operational infrastructure inside your hospital — staff, technology, formulary, payer access, and day-to-day management.
From licensing support and space planning to payer credentialing and formulary configuration — live inside your hospital without disrupting existing operations.
All pharmacy staff, formulary oversight, prior authorization support, patient adherence programs, and audit management — end-to-end, every day.
Integrated telehealth specialist access, specialty drug procurement, and white-glove patient navigation — connecting rural communities to care.
Three verticals where specialty pharmacy complexity is highest, 340B savings are greatest, and rural access gaps are most acute.
Complex neurological conditions demand specialist-coordinated care and high-cost specialty medications that most rural hospitals cannot manage without dedicated infrastructure.
Oral oncology agents and supportive care medications require specialty dispensing, clinical monitoring, and oncology-trained pharmacy staff — now available inside your CAH.
Biologics and DMARDs for autoimmune conditions represent significant 340B opportunity and enormous patient access challenges in rural markets.
One customer type. One regulatory framework. Three verticals.
| Dimension | ★ RECOMMENDEDVarickRX | Build Your Own | Contract Pharmacy | Vendor-Owned |
|---|---|---|---|---|
| License Ownership | ✓ Covered Entity | Covered Entity | Third-Party | Vendor |
| Drug Purchasing | ✓ Covered Entity | Covered Entity | Third-Party | Vendor |
| Time to Launch | 8–16 weeks | 18–24 months | 3–4 months | 12–18 months |
| Upfront Investment | $0 infrastructure | $500K–$3M+ | $0 | Varies |
| 340B Savings | ✓ Maximized | Full (if managed) | 12–65% extracted | 5–35% extracted |
| Specialty Expertise | ✓ Embedded | Must recruit & build | Limited | Varies |
| Telehealth Access | ✓ Included | Separate cost | ✗ | ✗ |
| Compliance Mgmt | ✓ Full scope | Must staff internally | Partial | Partial |
Select one of the five highest-margin specialty drugs, enter your patient count, and see your estimated annual 340B capture — the spread between Medicare reimbursement and your 340B acquisition cost.
Estimates based on CMS ASP+6% reimbursement less 340B ceiling price per dose. Actual capture varies by payer mix, adherence, and site volume. Not a financial guarantee.
Everything CAH administrators and 340B compliance officers need to know.
Talk to our team →Schedule a free operational assessment — including projected 340B savings and a realistic launch timeline for your hospital.